Clinical trials
Atrial Flutter trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
74 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 6 |
| 2005 | 6 |
| 2006 | 2 |
| 2008 | 3 |
| 2009 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 6 |
| 2015 | 2 |
| 2017 | 3 |
| 2018 | 8 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
| Terminated | 7 |
| Recruiting | 6 |
| Unknown status | 5 |
| Active, not recruiting | 3 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emory University | 5 |
| Boston Scientific Corporation | 4 |
| Sanofi | 4 |
| Wake Forest University Health Sciences | 4 |
| Solvay Pharmaceuticals | 3 |
| Abbott Medical Devices | 2 |
| Apple Inc. | 2 |
| Astellas Pharma Inc | 2 |
| Bristol-Myers Squibb | 2 |
| HeartBeam, Inc. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atrial Flutter | 74 |
| Atrial Fibrillation | 62 |
| Arrhythmias, Cardiac | 19 |
| Stroke | 5 |
| Tachycardia | 5 |
| Heart Failure | 4 |
| Tachycardia, Ventricular | 4 |
| Bradycardia | 3 |
| Inflammation | 3 |
| Tachycardia, Supraventricular | 3 |
Trials
Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.